Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01833325 · ClinicalTrials.gov registry record · NA
Proton Radiation Therapy for Macular Degeneration
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01833325 is a NA study that has completed, run by University of Florida. The registered enrollment target is 9 participants.
The verdict
NCT01833325, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a pilot study to determine if proton radiation therapy can provide effective and safe treatment for subfoveal neovascularization membrane (SNVM). The study will include adult patients over the age of 50 with macular degeneration, who have subfoveal neovascularization membrane (SNVM) and have had prior treatment with Avastin or Lucentis. Additional purposes of this study are to see if the growth of neovascular membranes can be stopped and overall vision improved with the use of protons and assess the side effects associated with this treatment.
Interventions
- RADIATION Proton radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-05 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01833325
The ClinicalTrials.gov registry entry for NCT01833325 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton radiation is the first listed.
NCT01833325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01833325 about?
NCT01833325 is a clinical study titled "Proton Radiation Therapy for Macular Degeneration". This is a pilot study to determine if proton radiation therapy can provide effective and safe treatment for subfoveal neovascularization membrane (SNVM). The study will include adult patients over the age of 50 with macular degeneration, who have subfoveal neovascularization membrane (SNVM) and have...
What is the current status of trial NCT01833325?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2013-05. Estimated completion is 2018-02.
What interventions are being tested in trial NCT01833325?
The interventions under investigation include: Proton radiation (RADIATION).
Who is sponsoring clinical trial NCT01833325?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.